Elevated IL6 has been linked to chemotherapy resistance in ovarian cancer by activating pro-survival signaling pathways, such as JAK/STAT3 and PI3K/AKT, which enable tumor cells to withstand chemotherapy-induced stress. Here, IL6 is linked to neoplasm.